APA

Dinnes D. L. M., White M. Y., Kockx M., Traini M., Hsieh V., Kim M., Hou L., Jessup W., Rye K., Thaysen-Andersen M., Cordwell S. J. & Kritharides L. (20170921). Human macrophage cathepsin B-mediated C-terminal cleavage of apolipoprotein A-I at Ser228 severely impairs antiatherogenic capacity. : FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Chicago

Dinnes Donna Lee M, White Melanie Y, Kockx Maaike, Traini Mathew, Hsieh Victar, Kim Mi-Jurng, Hou Liming, Jessup Wendy, Rye Kerry-Anne, Thaysen-Andersen Morten, Cordwell Stuart J and Kritharides Leonard. 20170921. Human macrophage cathepsin B-mediated C-terminal cleavage of apolipoprotein A-I at Ser228 severely impairs antiatherogenic capacity. : FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Harvard

Dinnes D. L. M., White M. Y., Kockx M., Traini M., Hsieh V., Kim M., Hou L., Jessup W., Rye K., Thaysen-Andersen M., Cordwell S. J. and Kritharides L. (20170921). Human macrophage cathepsin B-mediated C-terminal cleavage of apolipoprotein A-I at Ser228 severely impairs antiatherogenic capacity. : FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

MLA

Dinnes Donna Lee M, White Melanie Y, Kockx Maaike, Traini Mathew, Hsieh Victar, Kim Mi-Jurng, Hou Liming, Jessup Wendy, Rye Kerry-Anne, Thaysen-Andersen Morten, Cordwell Stuart J and Kritharides Leonard. Human macrophage cathepsin B-mediated C-terminal cleavage of apolipoprotein A-I at Ser228 severely impairs antiatherogenic capacity. : FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 20170921.